Literature DB >> 28831750

Imbalanced expression of polycistronic miRNA in acute myeloid leukemia.

Ryutaro Kotaki1, Hiroshi Higuchi1, Daisuke Ogiya2, Yasuhiro Katahira1, Natsumi Kurosaki1, Naoko Yukihira1, Jun Ogata1, Haruna Yamamoto1, Syakira Mohamad Alba3, Azran Azhim4, Tatsuo Kitajima3, Shigeaki Inoue5, Kazuhiro Morishita6, Koh Ono7, Ryo Koyama-Nasu8, Ai Kotani9,10.   

Abstract

miR-1 and miR-133 are clustered on the same chromosomal loci and are transcribed together as a single transcript that is positively regulated by ecotropic virus integration site-1 (EVI1). Previously, we described how miR-133 has anti-tumorigenic potential through repression of EVI1 expression. It has also been reported that miR-1 is oncogenic in the case of acute myeloid leukemia (AML). Here, we show that expression of miR-1 and miR-133, which have distinct functions, is differentially regulated between AML cell lines. Interestingly, the expression of miR-1 and EVI1, which binds to the promoter of the miR-1/miR-133 cluster, is correlative. The expression levels of TDP-43, an RNA-binding protein that has been reported to increase the expression, but inhibits the activity, of miR-1, were not correlated with expression levels of miR-1 in AML cells. Taken together, our observations raise the possibility that the balance of polycistronic miRNAs is regulated post-transcriptionally in a hierarchical manner possibly involving EVI1, suggesting that the deregulation of this balance may play some role in AML cells with high EVI1 expression.

Entities:  

Keywords:  AML; EVI1; miR-1; miR-133

Mesh:

Substances:

Year:  2017        PMID: 28831750     DOI: 10.1007/s12185-017-2314-1

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  24 in total

1.  The closely related rare and severe acute myeloid leukemias carrying EVI1 or PRDM16 rearrangements share singular biological features.

Authors:  Marion Eveillard; Jacques Delaunay; Steven Richebourg; Laurence Lodé; Richard Garand; Soraya Wuillème; François Duhoux; Hélène Antoine-Poirel; Catherine Godon; Marie C Béné
Journal:  Haematologica       Date:  2015-03       Impact factor: 9.941

Review 2.  Small RNA as a regulator of hematopoietic development, immune response in infection and tumorigenesis.

Authors:  Kazuki Okuyama; Jun Ogata; Natsuko Yamakawa; Bidisha Chanda; Ai Kotani
Journal:  Int J Hematol       Date:  2014-04-01       Impact factor: 2.490

3.  Stem cell gene expression programs influence clinical outcome in human leukemia.

Authors:  Kolja Eppert; Katsuto Takenaka; Eric R Lechman; Levi Waldron; Björn Nilsson; Peter van Galen; Klaus H Metzeler; Armando Poeppl; Vicki Ling; Joseph Beyene; Angelo J Canty; Jayne S Danska; Stefan K Bohlander; Christian Buske; Mark D Minden; Todd R Golub; Igor Jurisica; Benjamin L Ebert; John E Dick
Journal:  Nat Med       Date:  2011-08-28       Impact factor: 53.440

4.  High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.

Authors:  Stefan Gröschel; Sanne Lugthart; Richard F Schlenk; Peter J M Valk; Karina Eiwen; Chantal Goudswaard; Wim J L van Putten; Sabine Kayser; Leo F Verdonck; Michael Lübbert; Gert-Jan Ossenkoppele; Ulrich Germing; Ingo Schmidt-Wolf; Brigitte Schlegelberger; Jürgen Krauter; Arnold Ganser; Hartmut Döhner; Bob Löwenberg; Konstanze Döhner; Ruud Delwel
Journal:  J Clin Oncol       Date:  2010-03-22       Impact factor: 44.544

5.  EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2.

Authors:  M Gómez-Benito; A Conchillo; M A García; I Vázquez; M Maicas; C Vicente; I Cristobal; N Marcotegui; L García-Ortí; E Bandrés; M J Calasanz; M M Alonso; M D Odero
Journal:  Br J Cancer       Date:  2010-09-14       Impact factor: 7.640

6.  High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated.

Authors:  Sanne Lugthart; Ellen van Drunen; Yvette van Norden; Antoinette van Hoven; Claudia A J Erpelinck; Peter J M Valk; H Berna Beverloo; Bob Löwenberg; Ruud Delwel
Journal:  Blood       Date:  2008-02-13       Impact factor: 22.113

7.  The RNA-binding protein TDP-43 selectively disrupts microRNA-1/206 incorporation into the RNA-induced silencing complex.

Authors:  Isabelle N King; Valeria Yartseva; Donaldo Salas; Abhishek Kumar; Amy Heidersbach; D Michael Ando; Nancy R Stallings; Jeffrey L Elliott; Deepak Srivastava; Kathryn N Ivey
Journal:  J Biol Chem       Date:  2014-04-09       Impact factor: 5.157

8.  EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells.

Authors:  Anna Rommer; Birgit Steinmetz; Friederike Herbst; Hubert Hackl; Petra Heffeter; Daniela Heilos; Martin Filipits; Katarina Steinleitner; Shayda Hemmati; Irene Herbacek; Ilse Schwarzinger; Katharina Hartl; Pieter Rondou; Hanno Glimm; Kadin Karakaya; Alwin Krämer; Walter Berger; Rotraud Wieser
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

9.  Rbfox proteins regulate microRNA biogenesis by sequence-specific binding to their precursors and target downstream Dicer.

Authors:  Yu Chen; Lorena Zubovic; Fan Yang; Katherine Godin; Tom Pavelitz; Javier Castellanos; Paolo Macchi; Gabriele Varani
Journal:  Nucleic Acids Res       Date:  2016-03-21       Impact factor: 16.971

10.  Selective blockade of microRNA processing by Lin28.

Authors:  Srinivas R Viswanathan; George Q Daley; Richard I Gregory
Journal:  Science       Date:  2008-02-21       Impact factor: 47.728

View more
  3 in total

Review 1.  The MicroRNA Family Both in Normal Development and in Different Diseases: The miR-17-92 Cluster.

Authors:  Xiaodan Bai; Shengyu Hua; Junping Zhang; Shixin Xu
Journal:  Biomed Res Int       Date:  2019-02-03       Impact factor: 3.411

2.  Overexpression of miR-669m inhibits erythroblast differentiation.

Authors:  Ryutaro Kotaki; Masaharu Kawashima; Asuka Yamaguchi; Naoto Suzuki; Ryo Koyama-Nasu; Daisuke Ogiya; Kazuki Okuyama; Yuichiro Yamamoto; Masako Takamatsu; Natsumi Kurosaki; Kiyoshi Ando; Akihiko Murata; Masato Ohtsuka; So Nakagawa; Koko Katagiri; Ai Kotani
Journal:  Sci Rep       Date:  2020-08-11       Impact factor: 4.379

Review 3.  Significance of trogocytosis and exosome-mediated transport in establishing and maintaining the tumor microenvironment in lymphoid malignancies.

Authors:  Masaharu Kawashima; Hiroshi Higuchi; Ai Kotani
Journal:  J Clin Exp Hematop       Date:  2021-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.